The site is temporarily down due to maintenance. Sorry for the inconvenience.

The site is temporarily down due to maintenance. Sorry for the inconvenience.

Quality & Accuracy


The latest technologies

Speed ​​&

Uncarboxylated osteocalcin (ucOC) ((serum)

Known as: uncarboxylated (decarboxylated) osteocalcin
SKU: 1345


Study material: Venous blood
Response time (working day): 14
The test is done on an empty stomach: Yes
Home call service: Yes
Country: EU

General Information

Non-carboxylated osteocalcin is a protein produced by osteoblasts that regulates insulin secretion and insulin sensitivity, although the exact effects of these effects on glucose metabolism are not fully understood. It circulates in the blood. Unlike it, carboxylated osteocalcin remains in the bones.

Non-carboxylated osteocalcin is the circulating fraction of active osteocalcin. It is an important protein that balances bone minerals, binds to calcium, and regulates glucose levels. Osteoblasts regulate glucose metabolism through the influence of insulin on the non-carboxylated osteocalcin metabolism pathway. According to studies, when osteoblast-specific insulin receptors are destroyed, there is an increase in blood sugar levels and a decrease in non-carboxylated osteocalcin. In an experimental model, osteocalcin decarboxylation has been shown to occur in resorption lacunae, thereby increasing circulating uncarboxylated osteocalcin blood levels and increasing insulin signaling in osteoblasts, leading to osteoclast activation and bone resorption. These data are supported by the results of separate studies showing that damage to the insulin receptors in osteoblasts reduces the total amounts of osteocalcin and decarboxylated osteocalcin in the blood, causes impaired glucose tolerance and decreases insulin.

The results of studies prove that non-carboxylated osteocalcin regulates glucose metabolism, thereby influencing the course of diabetes and heart diseases. Obesity is an important risk factor in the development of diabetes and cardiovascular diseases because it causes insulin resistance. Non-carboxylated osteocalcin promotes insulin secretion and increases receptor sensitivity to insulin. A decrease in the level of osteocalcin (both forms) is associated with insulin resistance, hyperglycemia in the blood and the development of diabetes.

Decreased levels of total osteocalcin and non-carboxylated osteocalcin lead to metabolic syndrome, increased glycemia and triglyceride levels.

When should we take the test?

In the course of diseases with disturbance of bone exchange

In the course of diseases with disturbances in glucose and insulin metabolism

Possible interpretation of the results

The norm of non-carboxylated osteocalcin in serum is 0.6-3.3ng/ml.

Reference values


Research material

Venous blood


No prior preparation is required for research

Additional information

Testing process

Purchase a test Submission of material

Purchase a test

Submission of material

Results Online Consult a doctor

Results Online

Consult a doctor

Call Now Button